Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
Wednesday 16 September 2015 1:15 pm

GPs are catching cancer earlier in England, paving the way for higher survival rates

By: Sarah Spickernell

Add as a preferred source on Google

More people in England are being diagnosed with cancer before it reaches its most serious stage, according to new research by Public Health England (PHE). 
 
Between 2006 and 2013, the proportion of sufferers who were referred for testing by GPs during the disease's early development went up, resulting in a simultaneous decline in emergency hospital diagnoses from 25 per cent to 20 per cent. 

Read more: London and Thames Valley have highest cancer survival rates in England

In the case of lung cancer, which is one of the country's biggest killers, the proportion diagnosed through GP emergency referral went up from 22 per cent to 28 per cent over the seven-year period, while there was a corresponding fall in emergency diagnoses from 39 per cent to 35 per cent.
 
The findings, presented today at the PHE's annual conference, shed a positive light on the future of cancer survival in England – catching it before it reaches the emergency stage increases the likelihood that a patient will make a full recovery.
 
Read more: Only Scottish patients are getting the best new drugs on the NHS
 
Sara Hiom, director of early diagnosis at Cancer Research UK, said:
 
It’s really encouraging to see fewer people being diagnosed through emergency routes, because we know survival is poorer and the experience is worse for these patients. When cancer is caught early, we have more options for treatments and a far better chance of beating the disease.

England lagging in survival

While today's findings indicate cancer survival rate is set to improve, England still lags behind many of its western neighbours. 
 
According to the most recent figures from the World Health Organisation (WHO), 137 out of 100,000 people die from cancer each year in the UK, which is more than in most countries in Europe and beyond.

In fact, out of 192 countries studied, the UK had the 32nd highest number of deaths. In Europe, only Ireland, France, the Netherlands and Denmark were among the few nations with a higher rate. 
 
Julia Verne, head of clinical epidemiology at Public Health England, said:
The latest PHE data shows a positive trend in how cancer is diagnosed in England. The earlier the better if we are to catch up with comparable European countries and I am pleased that our work has been able to drive this.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Tech

Trending Articles

  • A £3bn reckoning that will reshape buy now, pay later

  • Government accelerates social media crackdown with midnight curfews

  • Bank of England governor opens door to ‘simplifying’ financial rulebook

  • First Trust Global Portfolios Management Limited Announces Distribution for certain sub-funds of First Trust Global Funds ICAV

  • Alkermes to Report Second Quarter Financial Results on July 28, 2026

More from City PM

  • People named Mark called upon to raise money at London charity golf day

    Sport Business
    Breaking news concept with digital globe and newspaper headlines on a blue background, representing global journalism.
  • GSK shares slip after buying US cancer treatment firm Nuvalent for $10.6bn

    Pharma
    GSK logo displayed prominently, signifying the companys presence and relevance in the business and healthcare sectors.
  • Anocca has Dosed First Patients with Precision TCR-T Cell Therapy Targeting Mutant KRAS in Pancreatic Cancer

    Business Wire
  • Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform

    Business Wire
  • Bank of England to relax capital rules despite warning of economic threats

    Banking
    Bank of England building on Threadneedle Street, London, showcasing its historic architecture and financial significance
  • Patent cliff fuels Novartis’ $1.5bn swoop for London biotech

    Healthcare
    Hikma produces generic drugs
  • Inflation expectations at record high in interest rates signal

    Economics
    Bank of England building on Threadneedle Street, London, showcasing its historic architecture and financial significance
  • Araris Biotech AG and Taiho Oncology Announce Dosing of First Patient in Phase 1 Trial of ARC-02, a Novel ADC for the Treatment of Non-Hodgkin Lymphoma

    Business Wire

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy · Facebook